Search Results
Search for other papers by Sihan Lv in
Google Scholar
PubMed
Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China
Search for other papers by Xinchen Qiu in
Google Scholar
PubMed
Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China
Search for other papers by Jian Li in
Google Scholar
PubMed
Search for other papers by Jinye Liang in
Google Scholar
PubMed
Search for other papers by Weida Li in
Google Scholar
PubMed
Search for other papers by Chao Zhang in
Google Scholar
PubMed
Search for other papers by Zhen-Ning Zhang in
Google Scholar
PubMed
Search for other papers by Bing Luan in
Google Scholar
PubMed
glucose and lipid metabolism in response to hormonal signals. Dedicated transcription regulatory network is involved in the hepatic response to fasting. During the fasted state, one of the major circulating hormones required for liver function is glucagon
Search for other papers by Daniella B R Insuela in
Google Scholar
PubMed
Search for other papers by Julio B Daleprane in
Google Scholar
PubMed
Search for other papers by Luciana P Coelho in
Google Scholar
PubMed
Search for other papers by Adriana R Silva in
Google Scholar
PubMed
Search for other papers by Patrícia M R e Silva in
Google Scholar
PubMed
Search for other papers by Marco A Martins in
Google Scholar
PubMed
Search for other papers by Vinicius F Carvalho in
Google Scholar
PubMed
Introduction Glucagon is a 29-amino-acid peptide hormone secreted during fasting periods by the pancreatic islet α-cells into hepatic portal venous circulation in response to falling glucose levels ( Conarello et al . 2007 , Cryer 2012 ). Glucagon
Search for other papers by Daniella Bianchi Reis Insuela in
Google Scholar
PubMed
Search for other papers by Maximiliano Ruben Ferrero in
Google Scholar
PubMed
Search for other papers by Amanda da Silva Chaves in
Google Scholar
PubMed
Search for other papers by Diego de Sá Coutinho in
Google Scholar
PubMed
Search for other papers by Nathalia dos Santos Magalhães in
Google Scholar
PubMed
Search for other papers by Ana Carolina Santos de Arantes in
Google Scholar
PubMed
Instituto Nacional de Ciência e Tecnologia em Neuroimunomodulação (INCT-NIM), Fundação Oswaldo Cruz, Manguinhos, Rio de Janeiro, Brazil
Search for other papers by Adriana Ribeiro Silva in
Google Scholar
PubMed
Search for other papers by Patrícia Machado Rodrigues e Silva in
Google Scholar
PubMed
Search for other papers by Marco Aurélio Martins in
Google Scholar
PubMed
Instituto Nacional de Ciência e Tecnologia em Neuroimunomodulação (INCT-NIM), Fundação Oswaldo Cruz, Manguinhos, Rio de Janeiro, Brazil
Search for other papers by Vinicius Frias Carvalho in
Google Scholar
PubMed
. 2018 , Cartwright et al. 2019 ). Glucagon is secreted by pancreatic alpha cells, responsible for mobilizing glucose stored in the liver, promoting an increase in blood glucose levels ( Jo et al. 2021 ). We previously demonstrated that pre
Search for other papers by Ryan A Lafferty in
Google Scholar
PubMed
Search for other papers by Laura M McShane in
Google Scholar
PubMed
Search for other papers by Zara J Franklin in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Finbarr P M O’Harte in
Google Scholar
PubMed
Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Introduction It has been well established that abnormal elevation in circulating glucagon leads to an increase in hepatic glucose production and glycogen metabolism that contribute to hyperglycaemia in diabetes ( Unger 1978 ). For this reason
Search for other papers by Toya M Albury-Warren in
Google Scholar
PubMed
Search for other papers by Veethika Pandey in
Google Scholar
PubMed
Search for other papers by Lina P Spinel in
Google Scholar
PubMed
Burnett School of Biomedical Sciences, Department of Head and Neck Surgery, College of Medicine, University of Central Florida, 6900 Lake Nona Boulevard, Orlando, Florida 32827, USA
Search for other papers by Michal M Masternak in
Google Scholar
PubMed
Search for other papers by Deborah A Altomare in
Google Scholar
PubMed
downregulation of the Akt1 Myr transgene reduced the non-fasted and fasted hyperglycemia to WT levels. Collectively, metabolic characterization of the AKT1 Myr mice revealed a novel glucagon-mediated mechanism by which AKT1 hyperactivation affects glucose
Search for other papers by L M McShane in
Google Scholar
PubMed
Search for other papers by N Irwin in
Google Scholar
PubMed
Search for other papers by D O’Flynn in
Google Scholar
PubMed
Search for other papers by Z J Franklin in
Google Scholar
PubMed
Search for other papers by C M Hewage in
Google Scholar
PubMed
Search for other papers by F P M O’Harte in
Google Scholar
PubMed
DM are present in the setting of glucagon excess ( Unger & Cherrington 2012 ). Thus, improved control of glucagon signaling represents a rational therapeutic target for T2DM. In agreement with this, early proof-of-concept studies using the orally
Search for other papers by Lyle Wiemerslage in
Google Scholar
PubMed
Search for other papers by Priya A Gohel in
Google Scholar
PubMed
Search for other papers by Giulia Maestri in
Google Scholar
PubMed
Search for other papers by Torfi G Hilmarsson in
Google Scholar
PubMed
Search for other papers by Michel Mickael in
Google Scholar
PubMed
Search for other papers by Robert Fredriksson in
Google Scholar
PubMed
Search for other papers by Michael J Williams in
Google Scholar
PubMed
Search for other papers by Helgi B Schiöth in
Google Scholar
PubMed
for studying a variety of molecular pathways, as well as behavior. Specifically for obesity, they have organs that function similar to the human pancreas with corresponding orthologs of insulin and glucagon: insulin-like protein 2 (Ilp2) and
Department of Clinical Sciences, North Carolina State University, College of Veterinary Medicine, Raleigh, North Carolina, USA
Search for other papers by Courtney A Deck in
Google Scholar
PubMed
United States Department of Agriculture, Agricultural Research Service, National Center for Cool and Cold Water Aquaculture, Kearneysville, West Virginia, USA
Search for other papers by Jamie L Mankiewicz in
Google Scholar
PubMed
Search for other papers by Russell J Borski in
Google Scholar
PubMed
as glucagon, in non-mammalian vertebrates. Zebrafish larvae lacking a functional leptin receptor exhibited increased beta-cell numbers and insulin a ( insa ) mRNA levels ( Michel et al. 2016 ). Further, an increase in lep levels in response to
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Search for other papers by Tricia Mei-Mei Tan in
Google Scholar
PubMed
gut hormone path-finder Glucagon-like peptide 1 (GLP-1) is the most extensively studied gut hormone with translational and clinical evidence for its efficacy ( Holst 2007 ). It is an alternatively processed product of the proglucagon peptide
Search for other papers by Zhongxiuzi Gao in
Google Scholar
PubMed
Search for other papers by Li Zhang in
Google Scholar
PubMed
Search for other papers by Wenting Xie in
Google Scholar
PubMed
Search for other papers by Siqi Wang in
Google Scholar
PubMed
Search for other papers by Xiaorui Bao in
Google Scholar
PubMed
Search for other papers by Yuli Guo in
Google Scholar
PubMed
Search for other papers by Houjian Zhang in
Google Scholar
PubMed
Search for other papers by Qingzhong Hu in
Google Scholar
PubMed
Search for other papers by Yi Chen in
Google Scholar
PubMed
Search for other papers by Zeen Wang in
Google Scholar
PubMed
Search for other papers by Maoqiang Xue in
Google Scholar
PubMed
Search for other papers by Guanghui Jin in
Google Scholar
PubMed
resulted in impairment of glucose metabolism in 12-month-old male mice; however, it did not induce insulin resistance. Instead, it promoted glucagon production and increased hepatic glucose output (HGO), which together contributed to increased glucose